Hello, Fool! | Login | Signup | My Fool
Sep 8, 2008 5:25 AM ET | Site Changes | Help
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.
View Ticker Page (NVO)
Results 1 - 10 of 43 : 12345
Recs
xthecritic (92.66) Submitted: 12/17/07 2:17 PM : Start Price: $52.39 NVO Score: 11.52
This is a sector play. Drug manufacturers have been and will continue to outperform the market in the next 12-18 months as we deal with economic weakness. I like the sector overall after several years of pressure from products coming off patent and...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
StinkingBishop (92.29) Submitted: 4/11/07 4:37 PM : Start Price: $46.14 NVO Score: 25.51
I travel to many companies for my work. This gives me a great opportunity that many do not get. To meet the people, see the manufacturing sites and learn about companies outlook on the future. It doesn't take long to get an overall sense of a comp...
knflarup (< 20) Submitted: 12/07/06 4:57 PM : Start Price: $39.67 NVO Score: 42.19
Novo Nordisk is the largest manufacture of insulin in the world and also a producer of enzymes used in detergents. Diabetes is one of the fastest growing diseases in the world today. Insulin dependent diabetics can have a long life time, so it goes w...
Hcurb1 (99.01) Submitted: 9/18/06 5:49 PM : Start Price: $36.24 NVO Score: 48.53
Novo Nordisk has increased substantially. However, the current valuation still seems reasonable at ~12-13 EV/EBITDA given margin levels and asset intensity. Additionally, this is as close to a pure play on diabetes as you can get, and diabetes is u...
ratskins (61.87) Submitted: 2/21/07 2:22 AM : Start Price: $44.01 NVO Score: 32.05
People are fat...and getting fatter. Novo-Nordisk and Eli Lilly are the two big suppliers of insulin. If you need insulin you will find a way to buy it, since the alternative is not so pleasant. Lilly has a lot of problems, so I vote for Novo. Plus, ...
wally140 (91.67) Submitted: 1/03/07 5:48 PM : Start Price: $40.10 NVO Score: 40.86
Leading provider of insulin and other diabetic products. Strong play as global diabetes increases and the US exports its unhealthy eating habits
carltahoe (67.56) Submitted: 11/13/06 12:25 PM : Start Price: $35.99 NVO Score: 50.13
Simple, Diabetes is a growing problem - and Novo is close to a pure play
chk999 (100.00) Submitted: 9/11/07 11:33 AM : Start Price: $57.02 NVO Score: 5.85
This is a Value Line pick, where the timeliness, safety, technicals and valuation all looked good.
jdlech (< 20) Submitted: 7/12/08 12:44 AM : Start Price: $64.66 NVO Score: -17.91
dividend yielding pharma.
biovestor (< 20) Submitted: 6/28/08 8:06 AM : Start Price: $65.90 NVO Score: -18.79
An innovative leader in the field of diabetes care, NVO is poised to continue its rapid growth based on the obesity and diabetes epidemic in the USA and other developed countries.
Terms & Conditions
RSS Headlines
Fool UK